Researchers at the University of Zurich have discovered a new approach to suppressing itch by targeting two receptors in the spinal cord with the right experimental drug. In a series of experiments in mice and dogs, they ...
Aug 15, 2018
0
31
Charcot-Marie-Tooth disease is the most common hereditary neuropathy and affects more than 2 million people worldwide. Researchers at the Max-Planck-Institute for Experimental Medicine and the University Medical Center of ...
Aug 9, 2018
0
507
A research team from Queen's University Belfast, in collaboration with an international team of experts, have made ground-breaking insights into how inflammatory diseases work.
Apr 23, 2018
0
1177
Researchers in the US have used genetic techniques to slow the progression of Alzheimer's in mice that show features of the disease. The study, which centered around a protein called BACE1, was reported today in the Journal ...
Feb 15, 2018
0
3
A team of scientists has discovered that mutations in the genes FOXC2 and GJC2 are associated with defects in venous valves, flaps within veins that help maintain proper blood flow.
Aug 14, 2017
0
8
In news that may bring hope to asthma sufferers, scientists discover a mechanism that provides a possible new target for allergy treatments.
Jun 5, 2017
0
42
Researchers in Japan have identified a receptor protein on the surface of heart cells that promotes chronic heart failure. The study, "Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction," which ...
May 26, 2017
0
5
'Timing is everything' in the transmission of signals between neurons in the brain. Most of the complex functions that humans are capable of performing would be severely impaired if their neurons were not capable of communicating ...
Feb 15, 2017
0
8
Mice placed on a low-calorie diet are less likely to develop abdominal aortic aneurysms, according to a new study in The Journal of Experimental Medicine. The paper, "Calorie restriction protects against experimental abdominal ...
Sep 26, 2016
0
3
Federal regulators on Monday granted tentative approval to the first drug for muscular dystrophy, following an intense public campaign from patients and doctors who pushed for the largely unproven medication.
Sep 19, 2016
0
1
